Evidence map›Paper›PMID 25790017›Full record

ArticlePloS one2015

East London experience with enteric fever 2007-2012.

Jayshree Dave, Michael Millar, Horst Maxeiner, Joanne Freedman, Rachel Meade, Caryn Rosmarin, Matthew Jordan, Nick Andrews, Richard Holliman, Armine Sefton

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Baseline Antibody Titre againstInternational journal of microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jayshree DavePublic Health Laboratory London, Public Health England, London, United Kingdom.
Michael MillarDivision of Infection, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Horst MaxeinerPublic Health Laboratory London, Public Health England, London, United Kingdom.
Joanne FreedmanTravel and Migrant Health Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom.
Rachel MeadePublic Health Laboratory London, Public Health England, London, United Kingdom.
Caryn RosmarinDivision of Infection, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Matthew JordanPublic Health Laboratory London, Public Health England, London, United Kingdom.
Nick AndrewsStatistics, Modelling and Economics Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom.
Richard HollimanPublic Health Laboratory London, Public Health England, London, United Kingdom.
Armine SeftonCentre of Immunology and Infectious Disease, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.
Public Health England · GBBarts Health NHS Trust · GBQueen Mary University of London · GBRoyal London Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe clinical presentation and epidemiology for patients with enteric fever at two hospitals in East London during 2007-2012 is described with the aim to identify preventive opportunities and to reduce the cost of treatment.

methodsA retrospective analysis of case notes from patients admitted with enteric fever during 2007 to 2012 with a microbiologically confirmed diagnosis was undertaken. Details on clinical presentation, travel history, demographic data, laboratory parameters, treatment, patient outcome and vaccination status were collected.

resultsClinical case notes were available for 98/129 (76%) patients including 69 Salmonella enterica serovar Typhi (S. Typhi) and 29 Salmonella enterica serovar Paratyphi (S. Paratyphi). Thirty-four patients (35%) were discharged from emergency medicine without a diagnosis of enteric fever and then readmitted after positive blood cultures. Seventy-one of the 98 patients (72%) were UK residents who had travelled abroad, 23 (23%) were foreign visitors/new entrants to the UK and four (4%) had not travelled abroad. Enteric fever was not considered in the initial differential diagnosis for 48/98 (49%) cases. The median length of hospital stay was 7 days (range 0-57 days). The total cost of bed days for managing enteric fever was £454,000 in the two hospitals (mean £75,666/year). Median time to clinical resolution was five days (range 1-20). Seven of 98 (7%) patients were readmitted with relapsed or continued infection. Six of the 71 (8%) patients had received typhoid vaccination, 34 (48%) patients had not received vaccination, and for 31 cases (44%) vaccination status was unknown.

conclusionsFurther interventions regarding education and vaccination of travellers and recognition of the condition by emergency medicine clinicians in travellers to South Asia is required.

Indexed as

AdolescentAdultAgedBiomarkersChildChild, PreschoolDemographyFemaleHospitalsHumansInfantLength of StayLondonMaleMiddle AgedRecurrenceBiomarkers

Identifiers

PMID25790017
PMCPMC4366366
OpenAlexW2038517112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.